Supernus Pharmaceuticals Inc (SUPN)

21.37
0.13 0.60
NASDAQ : Health Care
Prev Close 21.50
Open 21.39
Day Low/High 21.09 / 21.65
52 Wk Low/High 9.51 / 23.30
Volume 202.97K
Avg Volume 546.10K
Exchange NASDAQ
Shares Outstanding 49.42M
Market Cap 1.04B
EPS 0.30
P/E Ratio 61.85
Div & Yield N.A. (N.A)

Latest News

Supernus Pharmaceuticals (SUPN) Is Today's Perilous Reversal Stock

Supernus Pharmaceuticals (SUPN) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Supernus Pharmaceuticals (SUPN) as a "perilous reversal" (up big yesterday but down big today) candidate

Supernus Pharmaceuticals (SUPN): Today's Weak On High Volume Stock

Supernus Pharmaceuticals (SUPN): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Supernus Pharmaceuticals (SUPN) as a weak on high relative volume candidate

Commit To Purchase Supernus Pharmaceuticals At $15, Earn 13.5% Annualized Using Options

Commit To Purchase Supernus Pharmaceuticals At $15, Earn 13.5% Annualized Using Options

Investors considering a purchase of Supernus Pharmaceuticals Inc shares, but tentative about paying the going market price of $19.45/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $15 strike, which has a bid at the time of this writing of $1.10.

Supernus Pharmaceuticals (SUPN) Shares Cross Below 200 DMA

Supernus Pharmaceuticals (SUPN) Shares Cross Below 200 DMA

In trading on Wednesday, shares of Supernus Pharmaceuticals Inc crossed below their 200 day moving average of $15.71, changing hands as low as $15.28 per share. Supernus Pharmaceuticals Inc shares are currently trading off about 6.2% on the day.

SUPN Crosses Above Key Moving Average Level

SUPN Crosses Above Key Moving Average Level

In trading on Friday, shares of Supernus Pharmaceuticals Inc crossed above their 200 day moving average of $15.80, changing hands as high as $16.33 per share. Supernus Pharmaceuticals Inc shares are currently trading up about 6.3% on the day.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BC, BSFT, ECOL, FDX, LAND, SUPN, TX Downgrades: ENDP, USBI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Strong On High Relative Volume: Supernus Pharmaceuticals (SUPN)

Strong On High Relative Volume: Supernus Pharmaceuticals (SUPN)

Trade-Ideas LLC identified Supernus Pharmaceuticals (SUPN) as a strong on high relative volume candidate

First Week of SUPN April 15th Options Trading

First Week of SUPN April 15th Options Trading

Investors in Supernus Pharmaceuticals Inc saw new options become available this week, for the April 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SUPN options chain for the new April 15th contracts and identified one put and one call contract of particular interest.

Supernus Prevails In Oxtellar XR® ANDA Litigation

Supernus Prevails In Oxtellar XR® ANDA Litigation

A Federal Court Finds Supernus Patents Valid and Actavis Infringing Two of Them

Strong On High Relative Volume: Supernus Pharmaceuticals (SUPN)

Strong On High Relative Volume: Supernus Pharmaceuticals (SUPN)

Trade-Ideas LLC identified Supernus Pharmaceuticals (SUPN) as a strong on high relative volume candidate

First Week of September 16th Options Trading For Supernus Pharmaceuticals (SUPN)

First Week of September 16th Options Trading For Supernus Pharmaceuticals (SUPN)

Investors in Supernus Pharmaceuticals Inc saw new options become available this week, for the September 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Supernus Pharmaceuticals is Now Oversold (SUPN)

Supernus Pharmaceuticals is Now Oversold (SUPN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Supernus Pharmaceuticals (SUPN)

Oversold Conditions For Supernus Pharmaceuticals (SUPN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Today's Dead Cat Bounce Stock Is Supernus Pharmaceuticals (SUPN)

Today's Dead Cat Bounce Stock Is Supernus Pharmaceuticals (SUPN)

Trade-Ideas LLC identified Supernus Pharmaceuticals (SUPN) as a "dead cat bounce" (down big yesterday but up big today) candidate